User profiles for Carla Coffin
carla coffinProfessor of Medicine Verified email at ucalgary.ca Cited by 5270 |
New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection
CS Coffin, K Zhou, NA Terrault - Gastroenterology, 2019 - Elsevier
Tests to detect the presence and activity of hepatitis B virus (HBV) are the cornerstones of
diagnosis and management. Assays that detect or measure serum levels of HB surface antigen…
diagnosis and management. Assays that detect or measure serum levels of HB surface antigen…
[HTML][HTML] Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
Chronic infection with viral hepatitis affects half a billion individuals worldwide and can lead
to cirrhosis, cancer, and liver failure. Liver cancer is the third leading cause of cancer-…
to cirrhosis, cancer, and liver failure. Liver cancer is the third leading cause of cancer-…
[PDF][PDF] Hepatitis B and pregnancy: virologic and immunologic characteristics
The hepatitis B virus (HBV) is an important human pathogen. Unvaccinated infants infected
through mother‐to‐child transmission (MTCT) are at >95% risk of developing serum hepatitis …
through mother‐to‐child transmission (MTCT) are at >95% risk of developing serum hepatitis …
A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends
…, KB Laupland, E Dixon, C Coffin… - Official journal of the …, 2010 - journals.lww.com
OBJECTIVES: Few population-based studies have evaluated pyogenic liver abscess (PLA)
in North America. We assessed the incidence of PLA and evaluated predictors of mortality. …
in North America. We assessed the incidence of PLA and evaluated predictors of mortality. …
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
…, JG McHutchison, S Kottilil, B Freilich, CS Coffin… - Journal of …, 2015 - Elsevier
Background & Aims GS-9620 is an oral agonist of toll-like receptor 7, a pattern-recognition
receptor whose activation results in innate and adaptive immune stimulation. We evaluated …
receptor whose activation results in innate and adaptive immune stimulation. We evaluated …
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
…, V Chulanov, L Cisneros, C Coffin… - The Lancet …, 2023 - thelancet.com
Background The 2016 World Health Assembly endorsed the elimination of hepatitis B virus (HBV)
infection as a public health threat by 2030; existing therapies and prophylaxis …
infection as a public health threat by 2030; existing therapies and prophylaxis …
Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy
…, SS Lee, SJ Urbanski, AI Aspinall, CS Coffin… - Canadian Journal of …, 2013 - hindawi.com
BACKGROUND: Although most patients with autoimmune hepatitis (AIH) respond to treatment
with prednisone and/or azathioprine, some patients are intolerant or refractory to standard …
with prednisone and/or azathioprine, some patients are intolerant or refractory to standard …
[HTML][HTML] Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease
Background Liver stiffness measurement (LSM) by transient elastography (TE, FibroScan) is
a validated method for noninvasively staging liver fibrosis. Most hepatic complications occur …
a validated method for noninvasively staging liver fibrosis. Most hepatic complications occur …
Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract
GR Martin, GW McKnight, MS Dicay, CS Coffin… - Digestive and Liver …, 2010 - Elsevier
AIMS: Hydrogen sulphide (H 2 S) exerts several anti-inflammatory effects, accelerates the
healing of experimental gastric ulcers, and can stimulate intestinal secretion. Little is known …
healing of experimental gastric ulcers, and can stimulate intestinal secretion. Little is known …
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
Background & Aims Peginterferon lambda-1a (lambda) is a Type-III interferon, which, like
alfa interferons, has antiviral activity in vitro against hepatitis B virus (HBV) and hepatitis C …
alfa interferons, has antiviral activity in vitro against hepatitis B virus (HBV) and hepatitis C …